SG11201510021TA - Compositions and methods for use in medical diagnosis - Google Patents

Compositions and methods for use in medical diagnosis

Info

Publication number
SG11201510021TA
SG11201510021TA SG11201510021TA SG11201510021TA SG11201510021TA SG 11201510021T A SG11201510021T A SG 11201510021TA SG 11201510021T A SG11201510021T A SG 11201510021TA SG 11201510021T A SG11201510021T A SG 11201510021TA SG 11201510021T A SG11201510021T A SG 11201510021TA
Authority
SG
Singapore
Prior art keywords
compositions
methods
medical diagnosis
diagnosis
medical
Prior art date
Application number
SG11201510021TA
Other languages
English (en)
Inventor
Laurence Poul
Laurent Levy
Céline Berjaud
Matthieu Germain
Agnès Pottier
Original Assignee
Nanobiotix
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanobiotix filed Critical Nanobiotix
Publication of SG11201510021TA publication Critical patent/SG11201510021TA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0409—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
    • A61K49/0414—Particles, beads, capsules or spheres
    • A61K49/0423—Nanoparticles, nanobeads, nanospheres, nanocapsules, i.e. having a size or diameter smaller than 1 micrometer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0457—Semi-solid forms, ointments, gels, hydrogels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5115—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Biomedical Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
SG11201510021TA 2013-06-20 2014-06-19 Compositions and methods for use in medical diagnosis SG11201510021TA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361837389P 2013-06-20 2013-06-20
EP13305831 2013-06-20
PCT/EP2014/062947 WO2014202723A1 (en) 2013-06-20 2014-06-19 Compositions and methods for use in medical diagnosis

Publications (1)

Publication Number Publication Date
SG11201510021TA true SG11201510021TA (en) 2016-01-28

Family

ID=48745869

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201510021TA SG11201510021TA (en) 2013-06-20 2014-06-19 Compositions and methods for use in medical diagnosis

Country Status (14)

Country Link
US (1) US10588987B2 (ja)
EP (1) EP3010495B1 (ja)
JP (1) JP6560665B2 (ja)
KR (1) KR20160027009A (ja)
CN (1) CN105431141A (ja)
AU (1) AU2014283217A1 (ja)
BR (1) BR112015031977A2 (ja)
CA (1) CA2915430A1 (ja)
EA (1) EA201690050A1 (ja)
HK (1) HK1222562A1 (ja)
MA (1) MA38709A1 (ja)
MX (1) MX2015017774A (ja)
SG (1) SG11201510021TA (ja)
WO (1) WO2014202723A1 (ja)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201403096VA (en) 2011-12-16 2014-07-30 Nanobiotix Nanoparticles comprising metallic and hafnium oxide materials, preparation and uses thereof
AR104806A1 (es) 2015-05-28 2017-08-16 Nanobiotix Nanopartículas para uso como vacuna terapéutica
CN105097174B (zh) * 2015-08-12 2018-06-22 华南理工大学 一种木聚糖季铵盐纳米磁性颗粒及其制备方法
AU2017384425B2 (en) * 2016-12-21 2023-08-31 Nanobiotix Nanoparticles for use for treating a neuronal disorder
MX2019007607A (es) * 2016-12-21 2019-08-29 Nanobiotix Nanoparticulas para su uso para potenciar rendimientos del cerebro o para tratar estres.
KR101949347B1 (ko) * 2017-05-24 2019-02-18 이화여자대학교 산학협력단 유방암의 재발 예측을 위한 정보제공방법
US11116793B2 (en) * 2017-11-13 2021-09-14 National University Corporation Hokkaido University Modified metal nanoparticle comprising cyclic polyether and pharmaceutical composition
CN107998395A (zh) * 2017-12-14 2018-05-08 天津市赛宁生物工程技术有限公司 一种双功能乳腺靶标及制备方法
WO2024126383A1 (en) 2022-12-12 2024-06-20 Nanobiotix (Nanobiotix S.A.) Novel metal oxide nanoparticles and compositions thereof for use as radioenhancers or for visualizing biological tissue

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6161034A (en) 1999-02-02 2000-12-12 Senorx, Inc. Methods and chemical preparations for time-limited marking of biopsy sites
US20050084869A1 (en) * 2003-10-20 2005-04-21 Sung Hyun Kim Novel composition and methods for the diagnosis of lung cancer
FR2869803B1 (fr) * 2004-05-10 2006-07-28 Nanobiotix Sarl Particules activables, preparation et utilisations
DE102006041495A1 (de) 2006-08-29 2008-03-20 Friedrich-Schiller-Universität Jena Substanzgemisch zur lokalen Deposition von Magnetpartikeln in einem Medium, insbesondere in tumorbefallenem organischem Gewebe, sowie Applikationskit zur Verabreichung
DE102008008522A1 (de) * 2008-02-11 2009-08-13 Magforce Nanotechnologies Ag Implantierbare Nanopartikel-enthaltende Produkte
EP2130553A1 (en) 2008-06-05 2009-12-09 Nanobiotix Inorganic nanoparticles of high density to destroy cells in-vivo
EP2275137A1 (en) * 2009-07-10 2011-01-19 Nanobiotix Metallic nanoparticles, preparation and uses thereof
JP5820815B2 (ja) 2009-12-15 2015-11-24 インセプト・リミテッド・ライアビリティ・カンパニーＩｎｃｅｐｔ，Ｌｌｃ インプラントおよび生体分解性基準マーカー
US10064960B2 (en) 2011-11-25 2018-09-04 Danmarks Tekniske Universitet Formulation of solid nano-sized particles in a gel-forming system
SG11201403096VA (en) * 2011-12-16 2014-07-30 Nanobiotix Nanoparticles comprising metallic and hafnium oxide materials, preparation and uses thereof
US20140219926A1 (en) * 2013-02-01 2014-08-07 The Trustees Of Dartmouth College Biodegradable Iron Oxide Nanoparticle Gel for Tumor Bed Therapy
SG11201510468TA (en) * 2013-06-20 2016-01-28 Nanobiotix Compositions and methods for use in oncology

Also Published As

Publication number Publication date
JP2016527204A (ja) 2016-09-08
CN105431141A (zh) 2016-03-23
US10588987B2 (en) 2020-03-17
MX2015017774A (es) 2016-03-31
BR112015031977A2 (pt) 2017-07-25
WO2014202723A1 (en) 2014-12-24
JP6560665B2 (ja) 2019-08-14
CA2915430A1 (en) 2014-12-24
KR20160027009A (ko) 2016-03-09
MA38709A1 (fr) 2018-05-31
EP3010495A1 (en) 2016-04-27
AU2014283217A1 (en) 2015-12-24
HK1222562A1 (zh) 2017-07-07
US20160136303A1 (en) 2016-05-19
EA201690050A1 (ru) 2016-05-31
EP3010495B1 (en) 2021-06-16

Similar Documents

Publication Publication Date Title
HK1217651A1 (zh) 固溶體組合物及其在劇痛中的用途
GB202005994D0 (en) Patient interface and aspects thereof
IL286759A (en) Therapeutic methods and preparations
EP2804550A4 (en) MEDICAL DEVICE AND ASSOCIATED METHODS
HK1222562A1 (zh) 用於醫學診斷的組合物及方法
GB201317286D0 (en) Composition and Use
EP2976044A4 (en) COMPOSITIONS AND METHODS FOR PROMOTING REGENERATION OF DENTAL TISSUE
GB2516343B (en) Improvements in and relating to ophthalmoscopes
EP2991627A4 (en) BLOOD SUCCANTED COMPOSITION AND METHOD OF USE
IL242584B (en) An immunogenic preparation for use in treatment
GB201309375D0 (en) Medical methods and compounds for medical use
EP2941293A4 (en) COMPOSITE YARNS USED IN MEDICAL PROCEDURES AND ASSOCIATED METHODS
GB201308753D0 (en) Compounds and their use in therapy
GB201307872D0 (en) Medical use
GB201309498D0 (en) Novel diagnosis and therapy
ZA201508585B (en) Immunogenic composition for use in therapy
GB201309379D0 (en) Medical methods and compounds for medical use
GB201309376D0 (en) Medical methods and compounds for medical use
GB201320958D0 (en) Improvements in and relating to medical devices
GB201300815D0 (en) Device for use in surgical procedure
GB201302884D0 (en) Novel methods for diagnosis and therapy
GB201319004D0 (en) Medical use
GB201322467D0 (en) Composition and use
GB201322508D0 (en) Dental frameworks and related methods
GB201319255D0 (en) Therapeutic compositions and methods